PHOENIX and VANCOUVER, British Columbia, Sept. 16, 2014 (GLOBE NEWSWIRE) -- Eternity Healthcare Inc. (OTC:ETAH), a medical device and diagnostic company with advanced technologies using the Needle-Free Injection system announced today that its competitor company, PharmaJet® Inc., has received FDA clearance to use a Needle-Free Injection device to administer the influenza vaccine to the public.
The following is from a release dated August 19, 2014:
" PharmaJet® Inc ., the developer of a needle-free injection technology to administer medications and vaccines to patients, and bioCSL Inc. , the maker of AFLURIA® (Influenza Vaccine) today announced the U.S. Food and Drug Administration (FDA) has approved the PharmaJet Stratis ® 0.5mL Needle-Free Jet Injector for delivery of AFLURIA in individuals aged 18 to 64 years. This is the first needle-free delivery system approved by the FDA for the administration of an inactivated influenza vaccine."
Dr. Salari, C.E.O. of Eternity Healthcare Inc. said, "With this new FDA approval, it opens the door for a large number of injectable drugs, from insulin to different types of vaccines and vitamins, to be injected without the use of needles." He went on to state: "Using a Needle-Free Injection Device to administer vaccines will not only be less painful, but will eliminate accidental poking and reducing the risk of transmitting diseases. This is truly important in developing countries." Dr. Salari further suggests that Eternity Healthcare Inc. is performing experimental work with some other types of vaccines using the Comfort-in™ Needle-Free Injection System.
About Eternity Healthcare
Eternity Healthcare or the "Company" (OTC:ETAH) is a healthcare company with technologies in medical devices and diagnostics. Our most advanced product is a needle-free injection system known as Comfort-in TM . Our products are sold to healthcare professionals, for use in physicians' offices, pharmacies, and to consumers directly. More information on Eternity Healthcare, visit the Company's website; www.eternityhealthcare.com .
Social Networks:
Twitter.com/EternityHealth
Facebook.com/EternityHealthcare
Safe Harbor Statement
This release includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as ETAH or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
Company Contact: Lena Kuang Sale Manager (855) 324-1110 Investor Relations Contact: Jonathan Hall Vital Media (347) 880-5457
